MAXIDEX Eye drops, suspension

Active ingredients: Dexamethasone

Product name and form

MAXIDEX 0.1% w/v, eye drops, suspension.

Pharmaceutical Form

Eye drops, suspension.

Qualitative and quantitative composition

Dexamethasone 0.1% w/v.

Excipient with known effect in suspension:

Benzalkonium Chloride 0.01% w/v.

For the full list excipients, see section 6.1.

Active Ingredient
Description

Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response.

List of Excipients

Sodium phosphate
Polysorbate 80
Disodium edetate
Sodium chloride
Benzalkonium chloride
Hypromellose
Citric acid
Purified water

Pack sizes and marketing

Drop-Tainer – 5ml and 10ml Natural Low Density Polyethylene Bottles and Plugs.

Polystyrene or Polypropylene cap.

Marketing Authorization Holder
Authorization Dates

Novartis Pharmaceuticals UK Limited, 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ, United Kingdom

28/09/1990 / 17/09/2003

Marketing authorization number:

PL 00101/0999

Drugs

Drug
Countries
Australia, Canada, Cyprus, Spain, France, Hong Kong, Lithuania, Singapore, United Kingdom, United States